Literature DB >> 29141174

Diuretic Treatment in Heart Failure.

David H Ellison1, G Michael Felker1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29141174      PMCID： PMC5811193          DOI： 10.1056/NEJMra1703100

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  76 in total

Review 1.  Loop diuretics: from the Na-K-2Cl transporter to clinical use.

Authors:  Sudha S Shankar; D Craig Brater
Journal:  Am J Physiol Renal Physiol       Date:  2003-01

2.  Early ultrafiltration in patients with decompensated heart failure and diuretic resistance.

Authors:  Maria Rosa Costanzo; Mitchell Saltzberg; Jeanne O'Sullivan; Paul Sobotka
Journal:  J Am Coll Cardiol       Date:  2005-11-09       Impact factor: 24.094

Review 3.  Integrated control of Na transport along the nephron.

Authors:  Lawrence G Palmer; Jürgen Schnermann
Journal:  Clin J Am Soc Nephrol       Date:  2014-08-06       Impact factor: 8.237

4.  Diuretic strategies in patients with acute decompensated heart failure.

Authors:  G Michael Felker; Kerry L Lee; David A Bull; Margaret M Redfield; Lynne W Stevenson; Steven R Goldsmith; Martin M LeWinter; Anita Deswal; Jean L Rouleau; Elizabeth O Ofili; Kevin J Anstrom; Adrian F Hernandez; Steven E McNulty; Eric J Velazquez; Abdallah G Kfoury; Horng H Chen; Michael M Givertz; Marc J Semigran; Bradley A Bart; Alice M Mascette; Eugene Braunwald; Christopher M O'Connor
Journal:  N Engl J Med       Date:  2011-03-03       Impact factor: 91.245

Review 5.  The physiologic basis of diuretic synergism: its role in treating diuretic resistance.

Authors:  D H Ellison
Journal:  Ann Intern Med       Date:  1991-05-15       Impact factor: 25.391

6.  Heart failure: SGLT2 inhibitors and heart failure -- clinical implications.

Authors:  Itamar Raz; Avivit Cahn
Journal:  Nat Rev Cardiol       Date:  2016-03-10       Impact factor: 32.419

7.  Decongestion strategies and renin-angiotensin-aldosterone system activation in acute heart failure.

Authors:  Robert J Mentz; Susanna R Stevens; Adam D DeVore; Anuradha Lala; Justin M Vader; Omar F AbouEzzeddine; Prateeti Khazanie; Margaret M Redfield; Lynne W Stevenson; Christopher M O'Connor; Steven R Goldsmith; Bradley A Bart; Kevin J Anstrom; Adrian F Hernandez; Eugene Braunwald; G Michael Felker
Journal:  JACC Heart Fail       Date:  2014-10-31       Impact factor: 12.035

8.  Modulation of salt transport rate affects DNA synthesis in vivo in rat renal tubules.

Authors:  J Loffing; M Le Hir; B Kaissling
Journal:  Kidney Int       Date:  1995-06       Impact factor: 10.612

Review 9.  Low-dose segmental blockade of the nephron rather than high-dose diuretic monotherapy.

Authors:  H Knauf; E Mutschler
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

10.  Assessment of renal hemodynamic effects of nesiritide in patients with heart failure using intravascular Doppler and quantitative angiography.

Authors:  Uri Elkayam; Mohamed W Akhter; Ming Liu; Parta Hatamizadeh; Mohamad N Barakat
Journal:  JACC Cardiovasc Imaging       Date:  2008-11
View more
  57 in total

1.  Effects of European Society of Cardiology guidelines on medication profiles after hospitalization for heart failure in 22,476 Dutch patients: from 2001 until 2015.

Authors:  Willemien J Kruik-Kollöffel; Gerard C M Linssen; H Joost Kruik; Kris L L Movig; Edith M Heintjes; Job van der Palen
Journal:  Heart Fail Rev       Date:  2019-07       Impact factor: 4.214

2.  Prevalence and outcome of diuretic resistance in heart failure: comment.

Authors:  Edgar Francisco Carrizales-Sepúlveda; Raymundo Vera-Pineda; Raúl Alberto Jiménez-Castillo; Mario Alberto Benavides-González; Alejandro Ordaz-Farías
Journal:  Intern Emerg Med       Date:  2019-02-20       Impact factor: 3.397

3.  Clinical Pharmacology in Diuretic Use.

Authors:  David H Ellison
Journal:  Clin J Am Soc Nephrol       Date:  2019-04-01       Impact factor: 8.237

4.  [Cardiovascular pharmacotherapy and coronary revascularization in end-stage renal failure].

Authors:  L Lauder; S Ewen; I E Emrich; M Böhm; F Mahfoud
Journal:  Herz       Date:  2019-11       Impact factor: 1.443

Review 5.  Loop diuretics in chronic heart failure: how to manage congestion?

Authors:  Justas Simonavičius; Christian Knackstedt; Hans-Peter Brunner-La Rocca
Journal:  Heart Fail Rev       Date:  2019-01       Impact factor: 4.214

Review 6.  Loop diuretic resistance complicating acute heart failure.

Authors:  Zachary L Cox; Jeffrey M Testani
Journal:  Heart Fail Rev       Date:  2020-01       Impact factor: 4.214

Review 7.  Decompensated Heart Failure and Renal Failure: What Is the Current Evidence?

Authors:  Agata Bielecka-Dabrowa; Breno Godoy; Joerg C Schefold; Michael Koziolek; Maciej Banach; Stephan von Haehling
Journal:  Curr Heart Fail Rep       Date:  2018-08

8.  Creation of a restrictive atrial communication in heart failure with preserved and mid-range ejection fraction: effective palliation of left atrial hypertension and pulmonary congestion.

Authors:  Anna Bauer; Markus Khalil; Monika Lüdemann; Jürgen Bauer; Anoosh Esmaeili; Roberta De-Rosa; Norbert F Voelkel; Hakan Akintuerk; Dietmar Schranz
Journal:  Clin Res Cardiol       Date:  2018-04-16       Impact factor: 5.460

9.  Diuretic treatment in high-risk acute decompensation of advanced chronic heart failure-bolus intermittent vs. continuous infusion of furosemide: a randomized controlled trial.

Authors:  Simone Frea; Stefano Pidello; Alessandra Volpe; Federico Giovanni Canavosio; Alessandro Galluzzo; Virginia Bovolo; Antonio Camarda; Pier Giorgio Golzio; Fabrizio D'Ascenzo; Serena Bergerone; Mauro Rinaldi; Fiorenzo Gaita
Journal:  Clin Res Cardiol       Date:  2019-06-29       Impact factor: 5.460

10.  Intensification of pharmacological decongestion but not the actual daily loop diuretic dose predicts worse chronic heart failure outcome: insights from TIME-CHF.

Authors:  Justas Simonavičius; Micha T Maeder; Casper G M J Eurlings; Arantxa Barandiarán Aizpurua; Jelena Čelutkienė; Jūratė Barysienė; Stefan Toggweiler; Beat A Kaufmann; Hans-Peter Brunner-La Rocca
Journal:  Clin Res Cardiol       Date:  2020-11-20       Impact factor: 5.460
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.